Details
Stereochemistry | ACHIRAL |
Molecular Formula | C18H12N2O6S.2Na |
Molecular Weight | 430.342 |
Optical Activity | NONE |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 1 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
[Na+].[Na+].CC1=CC=C(\N=N\C2=C3C=CC=CC3=CC(C([O-])=O)=C2O)C(=C1)S([O-])(=O)=O
InChI
InChIKey=VPWFPZBFBFHIIL-LLIZZRELSA-L
InChI=1S/C18H14N2O6S.2Na/c1-10-6-7-14(15(8-10)27(24,25)26)19-20-16-12-5-3-2-4-11(12)9-13(17(16)21)18(22)23;;/h2-9,21H,1H3,(H,22,23)(H,24,25,26);;/q;2*+1/p-2/b20-19+;;
D&C Red No. 6 is an excipient (pharmacologically inactive substance). It is FDA-approved, high-purity pigment. It can be tinted with titanium dioxide to create light red/pink shades. The color additive D&C Red No. 6 is principally the disodium salt of 3-hydroxy-4-[(4-methyl-2-sulfophenyl)azo]-2-naphthalenecarboxylic acid. To manufacture the additive, 2-amino-5-methylbenzenesulfonic acid is diazotized with hydrochloric acid and sodium nitrite. The diazo compound is coupled in alkaline medium with 3-hydroxy-2-naphthalenecarboxylic acid. The resulting dye precipitates as the disodium salt. D&C Red No. 6 is used in decorative cosmetic products including lipsticks, nail lacquers & face makeup (in USA prohibited for eye makeup), personal care products, soaps.
Approval Year
Name | Type | Language | ||
---|---|---|---|---|
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Official Name | English | ||
|
Common Name | English | ||
|
Official Name | English | ||
|
Systematic Name | English | ||
|
Official Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Official Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English |
Classification Tree | Code System | Code | ||
---|---|---|---|---|
|
NCI_THESAURUS |
C461
Created by
admin on Fri Dec 15 15:43:29 GMT 2023 , Edited by admin on Fri Dec 15 15:43:29 GMT 2023
|
||
|
CFR |
21 CFR 74.1306
Created by
admin on Fri Dec 15 15:43:29 GMT 2023 , Edited by admin on Fri Dec 15 15:43:29 GMT 2023
|
||
|
CFR |
21 CFR 74.2306
Created by
admin on Fri Dec 15 15:43:29 GMT 2023 , Edited by admin on Fri Dec 15 15:43:29 GMT 2023
|
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
481744AI4O
Created by
admin on Fri Dec 15 15:43:29 GMT 2023 , Edited by admin on Fri Dec 15 15:43:29 GMT 2023
|
PRIMARY | |||
|
481744AI4O
Created by
admin on Fri Dec 15 15:43:29 GMT 2023 , Edited by admin on Fri Dec 15 15:43:29 GMT 2023
|
PRIMARY | |||
|
5858-81-1
Created by
admin on Fri Dec 15 15:43:29 GMT 2023 , Edited by admin on Fri Dec 15 15:43:29 GMT 2023
|
PRIMARY | |||
|
DTXSID6064038
Created by
admin on Fri Dec 15 15:43:29 GMT 2023 , Edited by admin on Fri Dec 15 15:43:29 GMT 2023
|
PRIMARY | |||
|
C71667
Created by
admin on Fri Dec 15 15:43:29 GMT 2023 , Edited by admin on Fri Dec 15 15:43:29 GMT 2023
|
PRIMARY | |||
|
1311178
Created by
admin on Fri Dec 15 15:43:29 GMT 2023 , Edited by admin on Fri Dec 15 15:43:29 GMT 2023
|
PRIMARY | RxNorm | ||
|
227-497-9
Created by
admin on Fri Dec 15 15:43:29 GMT 2023 , Edited by admin on Fri Dec 15 15:43:29 GMT 2023
|
PRIMARY |
SUBSTANCE RECORD